Orpyx® launches Orpyx SI Sensory Insoles with Remote Patient Monitoring to Prevent Diabetic Foot Ulcers

A VA Angels Diversified Fund 1 Portfolio Company

Orpyx® Medical Technologies Inc. (Orpyx), an innovator in digital health therapeutics, announced the launch of Orpyx SI Sensory Insoles with Remote Patient Monitoring for the prevention of diabetic foot ulcers (DFU) and neuropathy-related ulcers. By monitoring pressure, temperature, and movement, the Orpyx SI Sensory Insole system provides the wearer with real-time audiovisual alerts and allows them to immediately take action to resolve high-pressure areas that may lead to tissue breakdown. Through a cloud-based dashboard, healthcare providers can monitor real-world data and identify trends to proactively make treatment decisions to help keep their patients’ feet healthy. To learn more about our product visit here.

READ MORE

Leave a Comment